Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and Gonorrhea

moxifloxacin has been researched along with Gonorrhea in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Allen, GP; Deao, KM; Hill, SA; Schipelliti, SM; Tran, T1
Bertholet, L; Blore, B; Brandley, J; Bull, A; Chernesky, M; Gratrix, J; Martin, I; Naidu, P; Parker, P; Plitt, S; Read, R; Scarrott, R; Shokoples, S; Singh, A; Smyczek, P; Turnbull, L1
Aung, E; Bradshaw, CS; Chen, MY; Chow, EPF; Fairley, CK; Garland, SM; Murray, G; Ong, JJ; Read, TRH1
Fernandes, P; Jensen, JS; Unemo, M1
Aguilar, L; Garcia-Mendez, E; Jiménez De Anta, MT; Marco, F; Mensa, J; Ruiz, J; Sierra, JM; Vila, J1

Other Studies

5 other study(ies) available for moxifloxacin and Gonorrhea

ArticleYear
In vitro evaluation of antimicrobial resistance selection in Neisseria gonorrhoeae.
    International journal of antimicrobial agents, 2021, Volume: 58, Issue:4

    Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Doxycycline; Drug Resistance, Multiple, Bacterial; Ertapenem; Gentamicins; Gonorrhea; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Neisseria gonorrhoeae

2021
Prevalence and antibiotic resistance of
    BMJ open, 2017, Jul-10, Volume: 7, Issue:7

    Topics: Adult; Alberta; Anti-Bacterial Agents; Cervix Uteri; Chlamydia Infections; Chlamydia trachomatis; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Fluoroquinolones; Gonorrhea; Humans; Logistic Models; Macrolides; Male; Moxifloxacin; Multivariate Analysis; Mycoplasma genitalium; Mycoplasma Infections; Neisseria gonorrhoeae; Sex Factors; Urine; Young Adult

2017
Clinical Characteristics of Anorectal Mycoplasma genitalium Infection and Microbial Cure in Men Who Have Sex With Men.
    Sexually transmitted diseases, 2018, Volume: 45, Issue:8

    Topics: Adult; Anti-Infective Agents; Azithromycin; Chlamydia trachomatis; Coinfection; Gonorrhea; Homosexuality, Male; Humans; Male; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Neisseria gonorrhoeae; Pristinamycin; Proctitis; Rectal Diseases; Sexual and Gender Minorities; Sexual Behavior; Victoria; Young Adult

2018
In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Anti-Bacterial Agents; Azithromycin; DNA, Bacterial; DNA, Ribosomal; Doxycycline; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycoplasma genitalium; Mycoplasma Infections; Neisseria gonorrhoeae; Triazoles

2014
In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene.
    International journal of antimicrobial agents, 2003, Volume: 22, Issue:1

    Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Genes, Bacterial; Gonorrhea; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Nalidixic Acid; Naphthyridines; Neisseria gonorrhoeae; Ofloxacin; Quinolines

2003